Jefferies Group LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$35,769,000
-40.1%
1,539,100
-59.0%
0.20%
-37.7%
Q1 2018$59,736,000
-49.8%
3,752,238
-34.5%
0.32%
-42.5%
Q4 2017$119,038,000
+610.0%
5,728,500
+389.6%
0.56%
+407.3%
Q3 2017$16,767,000
-33.6%
1,170,045
-19.9%
0.11%
-34.9%
Q2 2017$25,264,000
-63.9%
1,460,357
-77.0%
0.17%
-67.6%
Q1 2017$69,998,000
+89.0%
6,346,130
+148.8%
0.52%
+150.5%
Q4 2016$37,043,000
-3.3%
2,551,174
+63.5%
0.21%
+5.1%
Q3 2016$38,318,000
+9.8%
1,560,797
-9.9%
0.20%
+24.5%
Q2 2016$34,898,000
-41.1%
1,732,747
-23.1%
0.16%
-53.4%
Q1 2016$59,247,000
+45.5%
2,252,744
+462.2%
0.34%
+47.6%
Q4 2015$40,728,000
+381.8%
400,674
+745.6%
0.23%
+371.4%
Q3 2015$8,454,000
-36.7%
47,386
-21.2%
0.05%
-29.0%
Q2 2015$13,366,000
-70.0%
60,165
-73.2%
0.07%
-72.4%
Q1 2015$44,608,000
-78.6%
224,538
-84.6%
0.25%
-79.5%
Q4 2014$208,131,000
+42.4%
1,454,337
+30.5%
1.22%
+22.3%
Q3 2014$146,192,000
+39.2%
1,114,267
+33.8%
1.00%
+12.5%
Q2 2014$105,045,000
+11782.9%
832,900
+12322.1%
0.89%
+9766.7%
Q1 2014$884,000
-91.2%
6,705
-92.2%
0.01%
-85.9%
Q4 2013$10,085,000
+1071.3%
85,900
+759.0%
0.06%
+611.1%
Q2 2013$861,00010,0000.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders